Condition
Osteomyelitis - Foot
Total Trials
5
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
5Total
Not Applicable (3)
P 3 (1)
P 4 (1)
Trial Status
Recruiting2
Not Yet Recruiting2
Withdrawn1
Clinical Trials (5)
Showing 5 of 5 trials
NCT07266753Phase 4Recruiting
Comparison of Oral Antibiotics For Bone Infections of the Leg and Foot
NCT05074147Phase 3WithdrawnPrimary
Comparison Between Two Durations of Antibiotherapy for Non-surgically-treated Diabetic Foot Osteomyelitis (CHRONOS-2)
NCT06628115Not ApplicableNot Yet RecruitingPrimary
Post Market Study of Cerament V/G in Pedal Osteomyelitis
NCT06388603Not ApplicableRecruitingPrimary
RCT on Bioactive Glass S53P4 in Diabetic Foot Osteomyelitis in the Forefoot (DFORCT)
NCT06262854Not ApplicableNot Yet Recruiting
Efficacy and Safety of Stimulan® for the Treatment of Diabetic Foot Osteomyelitis. The BIG D-FOOT Study
Showing all 5 trials